Second-generation antiandrogens: from discovery to standard of care in castration resistant prostate cancer

MA Rice, SV Malhotra, T Stoyanova - Frontiers in oncology, 2019 - frontiersin.org
Prostate cancer is the most commonly diagnosed cancer affecting men in the United States.
The prostate is a hormone-dependent gland in which androgen hormones testosterone and …

Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins

R Prakash, Y Zhang, W Feng… - Cold Spring Harbor …, 2015 - cshperspectives.cshlp.org
Homologous recombination (HR) is a major pathway for the repair of DNA double-strand
breaks in mammalian cells, the defining step of which is homologous strand exchange …

Germline mutations in ATM and BRCA1/2 distinguish risk for lethal and indolent prostate cancer and are associated with early age at death

R Na, SL Zheng, M Han, H Yu, D Jiang, S Shah… - European urology, 2017 - Elsevier
Background Germline mutations in BRCA1/2 and ATM have been associated with prostate
cancer (PCa) risk. Objective To directly assess whether germline mutations in these three …

Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer

E Castro, C Goh, D Olmos, E Saunders… - Journal of Clinical …, 2013 - ascopubs.org
Purpose To analyze the baseline clinicopathologic characteristics of prostate tumors with
germline BRCA1 and BRCA2 (BRCA1/2) mutations and the prognostic value of those …

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers

PC Fong, DS Boss, TA Yap, A Tutt, P Wu… - … England Journal of …, 2009 - Mass Medical Soc
Background The inhibition of poly (adenosine diphosphate [ADP]–ribose) polymerase
(PARP) is a potential synthetic lethal therapeutic strategy for the treatment of cancers with …

Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review

KEJ Hann, M Freeman, L Fraser, J Waller… - BMC public health, 2017 - Springer
Background Genetic testing for risk of hereditary cancer can help patients to make important
decisions about prevention or early detection. US and UK studies show that people from …

Germline mutations in ATM and BRCA1/2 are associated with grade reclassification in men on active surveillance for prostate cancer

HB Carter, B Helfand, M Mamawala, Y Wu, P Landis… - European urology, 2019 - Elsevier
Background Mutations in DNA repair genes are associated with aggressive prostate cancer
(PCa). Objective To assess whether germline mutations are associated with grade …

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients

Z Kote-Jarai, D Leongamornlert, E Saunders… - British journal of …, 2011 - nature.com
Background: A family history of prostate cancer (PrCa) is a strong risk factor for the disease,
indicating that inherited factors are important in this disease. We previously estimated that …

BRCA1 and BRCA2: 1994 and beyond

SA Narod, WD Foulkes - Nature Reviews Cancer, 2004 - nature.com
The discovery of the first gene associated with hereditary breast cancer, BRCA1, was
anticipated to greatly increase our understanding of both hereditary and sporadic forms of …

Inherited susceptibility to common cancers

WD Foulkes - New England Journal of Medicine, 2008 - Mass Medical Soc
This review deals with germ-line genes that increase susceptibility to five major types of
cancer: breast, lung, pancreatic, prostate, and colorectal cancer. Often familial, often …